nodes	percent_of_prediction	percent_of_DWPC	metapath
Ramelteon—MTNR1A—Circadian rythm related genes—SIK1—dilated cardiomyopathy	0.0606	0.0651	CbGpPWpGaD
Ramelteon—MTNR1B—Circadian rythm related genes—SIK1—dilated cardiomyopathy	0.0606	0.0651	CbGpPWpGaD
Ramelteon—MTNR1B—GPCRs, Class A Rhodopsin-like—MAS1—dilated cardiomyopathy	0.0335	0.036	CbGpPWpGaD
Ramelteon—MTNR1A—GPCRs, Class A Rhodopsin-like—MAS1—dilated cardiomyopathy	0.0335	0.036	CbGpPWpGaD
Ramelteon—MTNR1A—G alpha (i) signalling events—AGTR2—dilated cardiomyopathy	0.0152	0.0163	CbGpPWpGaD
Ramelteon—MTNR1A—G alpha (i) signalling events—CXCL2—dilated cardiomyopathy	0.0152	0.0163	CbGpPWpGaD
Ramelteon—MTNR1B—G alpha (i) signalling events—CXCL2—dilated cardiomyopathy	0.0152	0.0163	CbGpPWpGaD
Ramelteon—MTNR1B—G alpha (i) signalling events—AGTR2—dilated cardiomyopathy	0.0152	0.0163	CbGpPWpGaD
Ramelteon—MTNR1A—G alpha (i) signalling events—CXCR3—dilated cardiomyopathy	0.0141	0.0151	CbGpPWpGaD
Ramelteon—MTNR1B—G alpha (i) signalling events—CXCR3—dilated cardiomyopathy	0.0141	0.0151	CbGpPWpGaD
Ramelteon—MTNR1A—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.0141	0.0151	CbGpPWpGaD
Ramelteon—MTNR1B—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.0141	0.0151	CbGpPWpGaD
Ramelteon—MTNR1B—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.0131	0.0141	CbGpPWpGaD
Ramelteon—MTNR1A—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.0131	0.0141	CbGpPWpGaD
Ramelteon—MTNR1A—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.0127	0.0136	CbGpPWpGaD
Ramelteon—MTNR1B—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.0127	0.0136	CbGpPWpGaD
Ramelteon—MTNR1A—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.0121	0.013	CbGpPWpGaD
Ramelteon—MTNR1A—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.0121	0.013	CbGpPWpGaD
Ramelteon—MTNR1B—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.0121	0.013	CbGpPWpGaD
Ramelteon—MTNR1B—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.0121	0.013	CbGpPWpGaD
Ramelteon—MTNR1A—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.0112	0.012	CbGpPWpGaD
Ramelteon—MTNR1B—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.0112	0.012	CbGpPWpGaD
Ramelteon—MTNR1B—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.0109	0.0117	CbGpPWpGaD
Ramelteon—MTNR1A—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.0109	0.0117	CbGpPWpGaD
Ramelteon—MTNR1A—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.0108	0.0116	CbGpPWpGaD
Ramelteon—MTNR1B—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.0108	0.0116	CbGpPWpGaD
Ramelteon—CYP2C19—Melatonin metabolism and effects—ADRB1—dilated cardiomyopathy	0.0106	0.0114	CbGpPWpGaD
Ramelteon—MTNR1B—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.0103	0.011	CbGpPWpGaD
Ramelteon—MTNR1A—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.0103	0.011	CbGpPWpGaD
Ramelteon—MTNR1A—Circadian rythm related genes—FAS—dilated cardiomyopathy	0.00992	0.0107	CbGpPWpGaD
Ramelteon—MTNR1B—Circadian rythm related genes—FAS—dilated cardiomyopathy	0.00992	0.0107	CbGpPWpGaD
Ramelteon—MTNR1A—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.00927	0.00996	CbGpPWpGaD
Ramelteon—MTNR1B—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.00927	0.00996	CbGpPWpGaD
Ramelteon—MTNR1A—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.00918	0.00986	CbGpPWpGaD
Ramelteon—MTNR1A—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.00918	0.00986	CbGpPWpGaD
Ramelteon—MTNR1B—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.00918	0.00986	CbGpPWpGaD
Ramelteon—MTNR1B—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.00918	0.00986	CbGpPWpGaD
Ramelteon—MTNR1A—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.00879	0.00945	CbGpPWpGaD
Ramelteon—MTNR1B—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.00879	0.00945	CbGpPWpGaD
Ramelteon—MTNR1A—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.00853	0.00917	CbGpPWpGaD
Ramelteon—MTNR1B—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.00853	0.00917	CbGpPWpGaD
Ramelteon—CYP1A2—Melatonin metabolism and effects—ADRB1—dilated cardiomyopathy	0.00827	0.00888	CbGpPWpGaD
Ramelteon—MTNR1A—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.00826	0.00888	CbGpPWpGaD
Ramelteon—MTNR1B—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.00826	0.00888	CbGpPWpGaD
Ramelteon—MTNR1A—G alpha (i) signalling events—AGT—dilated cardiomyopathy	0.0082	0.00881	CbGpPWpGaD
Ramelteon—MTNR1B—G alpha (i) signalling events—AGT—dilated cardiomyopathy	0.0082	0.00881	CbGpPWpGaD
Ramelteon—MTNR1A—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.00706	0.00758	CbGpPWpGaD
Ramelteon—MTNR1B—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.00706	0.00758	CbGpPWpGaD
Ramelteon—MTNR1B—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.0067	0.0072	CbGpPWpGaD
Ramelteon—MTNR1A—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.0067	0.0072	CbGpPWpGaD
Ramelteon—MTNR1A—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.00652	0.00701	CbGpPWpGaD
Ramelteon—MTNR1B—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.00652	0.00701	CbGpPWpGaD
Ramelteon—MTNR1A—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.00519	0.00557	CbGpPWpGaD
Ramelteon—MTNR1B—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.00519	0.00557	CbGpPWpGaD
Ramelteon—MTNR1B—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.00519	0.00557	CbGpPWpGaD
Ramelteon—MTNR1A—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.00519	0.00557	CbGpPWpGaD
Ramelteon—Mental disability—Furosemide—dilated cardiomyopathy	0.00503	0.0724	CcSEcCtD
Ramelteon—MTNR1B—GPCR ligand binding—AGT—dilated cardiomyopathy	0.00497	0.00534	CbGpPWpGaD
Ramelteon—MTNR1A—GPCR ligand binding—AGT—dilated cardiomyopathy	0.00497	0.00534	CbGpPWpGaD
Ramelteon—MTNR1B—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.00482	0.00518	CbGpPWpGaD
Ramelteon—MTNR1A—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.00482	0.00518	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.00471	0.00506	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.00471	0.00506	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.00471	0.00506	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.00471	0.00506	CbGpPWpGaD
Ramelteon—CYP2C19—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.0047	0.00505	CbGpPWpGaD
Ramelteon—MTNR1A—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.00467	0.00502	CbGpPWpGaD
Ramelteon—MTNR1B—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.00467	0.00502	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.00438	0.00471	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.00438	0.00471	CbGpPWpGaD
Ramelteon—Anaphylactoid reaction—Furosemide—dilated cardiomyopathy	0.00434	0.0626	CcSEcCtD
Ramelteon—MTNR1B—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.00424	0.00456	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.00424	0.00456	CbGpPWpGaD
Ramelteon—MTNR1B—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.00399	0.00429	CbGpPWpGaD
Ramelteon—MTNR1A—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.00399	0.00429	CbGpPWpGaD
Ramelteon—CYP1A2—Aryl Hydrocarbon Receptor—CD36—dilated cardiomyopathy	0.00381	0.0041	CbGpPWpGaD
Ramelteon—Anaphylactic shock—Spironolactone—dilated cardiomyopathy	0.0038	0.0547	CcSEcCtD
Ramelteon—MTNR1A—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.00378	0.00407	CbGpPWpGaD
Ramelteon—MTNR1B—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.00378	0.00407	CbGpPWpGaD
Ramelteon—CYP1A2—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.00366	0.00394	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.00362	0.00389	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.00362	0.00389	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.00344	0.00369	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.00344	0.00369	CbGpPWpGaD
Ramelteon—Somnolence—Spironolactone—dilated cardiomyopathy	0.00338	0.0486	CcSEcCtD
Ramelteon—Anaphylactoid reaction—Lisinopril—dilated cardiomyopathy	0.00326	0.0469	CcSEcCtD
Ramelteon—MTNR1B—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.00313	0.00337	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.00313	0.00337	CbGpPWpGaD
Ramelteon—MTNR1A—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.00294	0.00316	CbGpPWpGaD
Ramelteon—MTNR1B—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.00294	0.00316	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.00291	0.00313	CbGpPWpGaD
Ramelteon—MTNR1A—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.00281	0.00302	CbGpPWpGaD
Ramelteon—MTNR1B—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.00281	0.00302	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.00278	0.00299	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.00278	0.00299	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.00278	0.00299	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.00278	0.00299	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.00274	0.00294	CbGpPWpGaD
Ramelteon—Influenza—Lisinopril—dilated cardiomyopathy	0.00273	0.0393	CcSEcCtD
Ramelteon—MTNR1A—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.00267	0.00287	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.00267	0.00287	CbGpPWpGaD
Ramelteon—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.0026	0.0374	CcSEcCtD
Ramelteon—MTNR1B—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.00259	0.00278	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.00259	0.00278	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling by GPCR—AGT—dilated cardiomyopathy	0.00255	0.00274	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling by GPCR—AGT—dilated cardiomyopathy	0.00255	0.00274	CbGpPWpGaD
Ramelteon—Upper respiratory tract infection—Lisinopril—dilated cardiomyopathy	0.00253	0.0365	CcSEcCtD
Ramelteon—Dizziness—Spironolactone—dilated cardiomyopathy	0.00251	0.0362	CcSEcCtD
Ramelteon—MTNR1B—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.00251	0.00269	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.00251	0.00269	CbGpPWpGaD
Ramelteon—Dysgeusia—Furosemide—dilated cardiomyopathy	0.00248	0.0357	CcSEcCtD
Ramelteon—Depression—Lisinopril—dilated cardiomyopathy	0.00242	0.0349	CcSEcCtD
Ramelteon—CYP1A2—Aryl Hydrocarbon Receptor—RAF1—dilated cardiomyopathy	0.00238	0.00256	CbGpPWpGaD
Ramelteon—Headache—Spironolactone—dilated cardiomyopathy	0.00238	0.0343	CcSEcCtD
Ramelteon—CYP1A2—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.00227	0.00244	CbGpPWpGaD
Ramelteon—Nausea—Spironolactone—dilated cardiomyopathy	0.00226	0.0325	CcSEcCtD
Ramelteon—MTNR1A—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.00214	0.0023	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.00214	0.0023	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.00213	0.00229	CbGpPWpGaD
Ramelteon—Anaphylactic shock—Furosemide—dilated cardiomyopathy	0.00207	0.0298	CcSEcCtD
Ramelteon—MTNR1B—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.00203	0.00218	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.00203	0.00218	CbGpPWpGaD
Ramelteon—Dysgeusia—Lisinopril—dilated cardiomyopathy	0.00186	0.0268	CcSEcCtD
Ramelteon—Somnolence—Furosemide—dilated cardiomyopathy	0.00184	0.0265	CcSEcCtD
Ramelteon—Fatigue—Furosemide—dilated cardiomyopathy	0.00178	0.0257	CcSEcCtD
Ramelteon—MTNR1B—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.00177	0.0019	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.00177	0.0019	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.00174	0.00187	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.00174	0.00187	CbGpPWpGaD
Ramelteon—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—dilated cardiomyopathy	0.00163	0.00176	CbGpPWpGaD
Ramelteon—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—dilated cardiomyopathy	0.00163	0.00176	CbGpPWpGaD
Ramelteon—Myalgia—Lisinopril—dilated cardiomyopathy	0.00162	0.0233	CcSEcCtD
Ramelteon—Arthralgia—Lisinopril—dilated cardiomyopathy	0.00162	0.0233	CcSEcCtD
Ramelteon—MTNR1B—Signaling Pathways—RAC1—dilated cardiomyopathy	0.00158	0.00169	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—RAC1—dilated cardiomyopathy	0.00158	0.00169	CbGpPWpGaD
Ramelteon—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—dilated cardiomyopathy	0.00156	0.00167	CbGpPWpGaD
Ramelteon—CYP1A2—Aryl Hydrocarbon Receptor—TNF—dilated cardiomyopathy	0.00156	0.00167	CbGpPWpGaD
Ramelteon—Anaphylactic shock—Lisinopril—dilated cardiomyopathy	0.00155	0.0223	CcSEcCtD
Ramelteon—MTNR1B—Signaling Pathways—AGT—dilated cardiomyopathy	0.00151	0.00162	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—AGT—dilated cardiomyopathy	0.00151	0.00162	CbGpPWpGaD
Ramelteon—Asthenia—Furosemide—dilated cardiomyopathy	0.00148	0.0213	CcSEcCtD
Ramelteon—Diarrhoea—Furosemide—dilated cardiomyopathy	0.00141	0.0204	CcSEcCtD
Ramelteon—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	0.00141	0.0203	CcSEcCtD
Ramelteon—Insomnia—Lisinopril—dilated cardiomyopathy	0.0014	0.0202	CcSEcCtD
Ramelteon—Somnolence—Lisinopril—dilated cardiomyopathy	0.00138	0.0198	CcSEcCtD
Ramelteon—Dizziness—Furosemide—dilated cardiomyopathy	0.00137	0.0197	CcSEcCtD
Ramelteon—Fatigue—Lisinopril—dilated cardiomyopathy	0.00134	0.0192	CcSEcCtD
Ramelteon—CYP2C19—Metabolism—ANKRD1—dilated cardiomyopathy	0.0013	0.00139	CbGpPWpGaD
Ramelteon—Headache—Furosemide—dilated cardiomyopathy	0.00129	0.0186	CcSEcCtD
Ramelteon—Nausea—Furosemide—dilated cardiomyopathy	0.00123	0.0177	CcSEcCtD
Ramelteon—CYP2C19—Metabolism—TAZ—dilated cardiomyopathy	0.00122	0.00131	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.00121	0.0013	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.00121	0.0013	CbGpPWpGaD
Ramelteon—Asthenia—Lisinopril—dilated cardiomyopathy	0.00111	0.016	CcSEcCtD
Ramelteon—CYP2C19—Metabolism—SDHA—dilated cardiomyopathy	0.0011	0.00118	CbGpPWpGaD
Ramelteon—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.00106	0.0153	CcSEcCtD
Ramelteon—MTNR1A—Signaling Pathways—RAF1—dilated cardiomyopathy	0.00104	0.00112	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—RAF1—dilated cardiomyopathy	0.00104	0.00112	CbGpPWpGaD
Ramelteon—Dizziness—Lisinopril—dilated cardiomyopathy	0.00103	0.0148	CcSEcCtD
Ramelteon—CYP1A2—Metabolism—ANKRD1—dilated cardiomyopathy	0.00101	0.00109	CbGpPWpGaD
Ramelteon—Headache—Lisinopril—dilated cardiomyopathy	0.000971	0.014	CcSEcCtD
Ramelteon—CYP1A2—Metabolism—TAZ—dilated cardiomyopathy	0.000949	0.00102	CbGpPWpGaD
Ramelteon—Nausea—Lisinopril—dilated cardiomyopathy	0.000921	0.0133	CcSEcCtD
Ramelteon—CYP1A2—Metabolism—SDHA—dilated cardiomyopathy	0.000859	0.000923	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—ANKRD1—dilated cardiomyopathy	0.000779	0.000837	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—TAZ—dilated cardiomyopathy	0.000733	0.000787	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—EGFR—dilated cardiomyopathy	0.000717	0.00077	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—EGFR—dilated cardiomyopathy	0.000717	0.00077	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	0.000672	0.000722	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—SDHA—dilated cardiomyopathy	0.000663	0.000712	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	0.000655	0.000703	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	0.000589	0.000633	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	0.000524	0.000563	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	0.00051	0.000548	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	0.000459	0.000494	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—GPX1—dilated cardiomyopathy	0.000299	0.000322	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—CD36—dilated cardiomyopathy	0.000292	0.000313	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—AGT—dilated cardiomyopathy	0.000262	0.000282	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—GPX1—dilated cardiomyopathy	0.000233	0.000251	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—CD36—dilated cardiomyopathy	0.000227	0.000244	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—AGT—dilated cardiomyopathy	0.000205	0.00022	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—GPX1—dilated cardiomyopathy	0.00018	0.000193	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—CD36—dilated cardiomyopathy	0.000175	0.000188	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—AGT—dilated cardiomyopathy	0.000158	0.00017	CbGpPWpGaD
